Michael W Lawlor

6PUBLICATIONS
63CO-AUTHORS
Molecular targetsInfant and child healthGene and molecular therapyMedical biochemistry - inorganic elements and compoundsMicroelectromechanical systems (MEMS)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 18, 2026
AAV8 gene therapy and dietary insults together precipitate cholestatic liver disease in a mouse model of X-linked myotubular myopathy.

Emanuela Pannia, Rebecca Simonian, Nesrin Sabha

|Nov 09, 2025
Establishment of normal myofiber size distribution in children and young adults.

Michael W Lawlor, Marta Margeta, Karra A Jones

|Sep 22, 2025
Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study.

Perry B Shieh, Wendy Hughes, Marie Wood

|Feb 19, 2025
Human skeletal muscle fiber heterogeneity beyond myosin heavy chains.

Roger Moreno-Justicia, Thibaux Van der Stede, Ben Stocks

|Aug 19, 2024
High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy.

Rebecca A Slick, Jessica Sutton, Margaret Haberman

|Jan 04, 2023
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy.

Sharla M Birch, Michael W Lawlor, Thomas J Conlon

Pageof 1

Frequent Collaborators

2 joint publications

Barry J Byrne

2 joint publications

Kirsten E Coleman

1 joint publications

Sharla M Birch

1 joint publications

Lee-Jae Guo